Cochrane Corner: Ocriplasmin—why isn’t it being used more?-Reference-Cited by-同舟云学术

Cochrane Corner: Ocriplasmin—why isn’t it being used more?

Published:2019-04-02 Issue:8 Volume:33 Page:1195-1197
ISSN:0950-222X
Container-title:Eye
language:en
Short-container-title:Eye

Author:

Grinton Michael,Steel David H

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

http://www.nature.com/articles/s41433-019-0407-1.pdf

Reference20 articles.

1. National Institute for Health and Care Excellence (NICE). Ocriplasmin for treating vitreomacular traction: Technology appraisal guidance. Available from: nice.org.uk/guidance/ta297 . 2013.

2. Stalmans P, Benz MS, Gandorfer A, Kampik A, Girach A, Pakola S, et al. Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med. 2012;367:606–15.

3. Neffendorf JE, Kirthi V, Pringle E, Jackson TL. Ocriplasmin for symptomatic vitreomacular adhesion. Cochrane Database Syst Rev2017, Issue 10. Art. No.: CD011874. https://doi.org/10.1002/14651858.CD011874.pub2 .

4. Chatziralli I, Theodossiadis G, Xanthopoulou P, Miligkos M, Sivaprasad S, Theodossiadis P. Ocriplasmin use for vitreomacular traction and macular hole: a meta-analysis and comprehensive review on predictive factors for vitreous release and potential complications. Graefes Arch Clin Exp Ophthalmol. 2016;254:1247–56.

5. Dugel PU, Tolentino M, Feiner L, Kozma P, Leroy A. Results of the 2-year ocriplasmin for treatment for symptomatic vitreomacular adhesion including macular hole (OASIS) randomized trial. Ophthalmology. 2016;123:2232–47.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacologic Vitreolysis;Reference Module in Neuroscience and Biobehavioral Psychology;2024

2. Pars Plana Vitrectomy for Vitreomacular Traction Resulting in Persistent Postoperative Loculated Foveal Subretinal Fluid;Journal of VitreoRetinal Diseases;2023-06-06

3. Vitrectomy and ILM peeling in rhesus macaque: pitfalls and tips for success;Eye;2022-11-28

4. Calculating the individual probability of successful ocriplasmin treatment in eyes with vitreomacular traction–Validation and refinement of a multivariable prediction model;PLOS ONE;2022-07-25

5. The past, present, and future of enzyme-based therapies;Drug Discovery Today;2022-01